76 (PB064): E7386 enhances both lenvatinib and anti-PD1 antitumor activity in HCC
Year: 2024
Type: article
Source: European Journal of Cancer
Authors: A. Mesropian Badalian, A. Gris-Oliver, J. Abril-Fornaguera, M. Piqué-Gili, M. Torres-Marcén, D. Camell-Raventós, J. Peix, E. Fernández-Martínez, U. Balaseviciute, J. Huguet-Pradell, I. Keraite, R. Esteban-Fabró, R. Pinyol, M. Bárcena-Varela, K.E. Lindblad, A. Lujambio, E. Guccione, S.N. Thung, D. Sia, J.M. Llovet
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403749170
